Golden State Wealth Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Golden State Wealth Management’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.46K	Hold	263	–	–	﹤0.01%	1280
2026 Q1	$3.9K	Hold	263	–	–	﹤0.01%	1254
2025 Q4	$4.2K	Hold	263	–	–	﹤0.01%	1271
2025 Q3	$2.91K	Hold	263	–	–	﹤0.01%	1340
2025 Q2	$2.23K	Hold	263	–	–	﹤0.01%	1345
2025 Q1	$2.12K	Hold	263	–	–	﹤0.01%	1309
2024 Q4	$2.36K	Buy	+263	New	+$2.15K	﹤0.01%	1233
2020 Q2	–	Sell	-450	Closed	-$7K	–	312
2020 Q1	$7K	Buy	+450	New	+$7.94K	﹤0.01%	676

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Golden State Wealth Management's AUPH Position: Q2 2026 in Review

Golden State Wealth Management held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 263 shares worth $4.46K. The position accounts for ﹤0.01% of the portfolio, ranked #1280.

Golden State Wealth Management first reported a position in AUPH in Q1 2020 and has held it in 8 quarters since. The position peaked at $7K in Q1 2020. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

Golden State Wealth Management held 263 shares of Aurinia Pharmaceuticals worth $4.46K as of Q2 2026.
Golden State Wealth Management left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
Aurinia Pharmaceuticals made up ﹤0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #1280 holding.
Golden State Wealth Management first reported a position in Aurinia Pharmaceuticals in Q1 2020 and has held it in 8 quarters since.
Golden State Wealth Management's Aurinia Pharmaceuticals position peaked at $7K in Q1 2020.
283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.